•
Mar 31, 2023

Cross Country Healthcare Q1 2023 Earnings Report

Cross Country Healthcare's first quarter results were announced, revealing revenue and profitability exceeding expectations, driven by strong execution across the business.

Key Takeaways

Cross Country Healthcare's Q1 2023 results showed revenue of $622.7 million, a net income of $29.4 million, and diluted EPS of $0.81. The company exceeded expectations for revenue and profitability, with physician staffing revenue growing by 75%. They also signed their first Intellify vendor-neutral client contract and repurchased 1.2 million shares of common stock.

Revenue, Adjusted EBITDA, and Adjusted EPS exceeded guidance ranges.

Highest revenue quarter in Company history for education and home care.

Physician Staffing revenue growth of 75% year-over-year.

First Intellify vendor-neutral client contract signed.

Total Revenue
$623M
Previous year: $789M
-21.0%
EPS
$0.84
Previous year: $1.7
-50.6%
Gross Profit
$139M
Previous year: $175M
-20.3%
Cash and Equivalents
$291K
Previous year: $1.21M
-75.9%
Free Cash Flow
$43.2M
Previous year: -$31.1M
-238.7%
Total Assets
$921M
Previous year: $916M
+0.4%

Cross Country Healthcare

Cross Country Healthcare

Cross Country Healthcare Revenue by Segment

Forward Guidance

For the second quarter of 2023, Cross Country Healthcare anticipates revenue between $530 million and $540 million, Adjusted EBITDA between $40.0 million and $45.0 million, and Adjusted EPS between $0.55 and $0.65. The company has updated its 2023 annual minimum guidance to at least $2.1 billion in revenue and in excess of $170 million in Adjusted EBITDA.

Revenue & Expenses

Visualization of income flow from segment revenue to net income